Ala-Kokko, L., et al., “Structure of cDNA Clones Coding for the Entire Preproα1 (III) Chain of Human Type III Precollagen,” Biochem. J. 260:509-516, 1989. |
Seibel, M.J., “Komponenten der extrazellulären Gewebematrix als potentialle . . . Marker des Bindegewebs-, Knorpel-und Knochenmetabolismus bei Erkrankungen des Bewegungsapparates,” Z. Rheumatol. 48:6-18, 1989. |
Niemelá, O., “Radioimmunoassays for Type III Procollagen Amino-Terminal Peptides in Humans,” Clin. Chem. 31(8):1301-1304, 1985. |
Loid, H.R., et al., “Molecular Cloning and Carboxyl-Propeptide Analysis of Human Type III Procollagen,” Nucleic Acids Research 12(24):9383-9394, 1984. |
Pierard, D., et al., “Radioimmunoassay for the Amino-Terminal Sequences of Type III Procollagen in Human Body Fluids Measuring Fragmented Precursor Sequences,” Analytical Biochem. 141:127-136, 1984. |
Rohde, H., et al., “Radioimmunoassay for Type III Procollagen Peptide and Its Application to Human Liver Disease,” Euro. J. Clin. Invest. 9:451-459, 1979. |
Eyre, D.R., “Cross-Linking in Collagen and Elastin,” Ann. Rev. Biochem. 53:717-748, 1984. |
Hasselbach, H., et al., “Procollagen Type III Aminoterminal Peptide in Serum in Idiopathic Myelofibrosis and Allied Conditions: Relation to Disease Activity and Effect of Chemotherapy,” Am. J. Hematol. 33:18-26, 1990. |
Hanson, D.A., et al., “A Specific Immunoassay for Monitoring Human Bone Resorption: Quantitation of Type I Collagen Cross-Linked N-Telopeptides in Urine,” J. Bone and Min. Res. 7(11):1251-1258, 1992. |
Lane, J.M., et al., “Immunofluorescent Localization of Structural Collagen Types in Endochondral Fracture Healing,” Orthopaedic Transactions VI(2):236, 1982. |
Kühn, K., “The Classical Collagens: Types I, II, and III,” in Structure and Function of Collagen Types, Academic Press, Inc., 1987, pp. 1-42. |
Stoltenberg, M., et al., “Intra-Articular and Circulating Levels of Type I and III Collagen Markers in Inflammatory and Degenerative Joint Disease,” Acta. Orthop. Scand. 66(Suppl 266):147-148, 1995. |
Eyre, D.R., et al., “Cross-Linked Telopeptides From Collagen Types I, II and III in Human Urine,” ASBMR Meeting, Sep. 1996. |
Horslev-Petersen, K., “Circulating Extracellular Matrix Components as Markers for Connective Tissue Response to Inflammation,” Danish Med. Bul. 37(4):308-329, 1990. |
Hanson, D.A., and D.R. Eyre, “Molecular Site Specificity of Pyridinoline and Pyrrole Cross-Links in Type I Collagen of Human Bone,” J. Biol. Chem. 271(43):26508-26516, 1996. |
Myllylä, R., et al., “Markers of Collagen Metabolism in Sera of Patients With Various Rheumatic Diseases,” Clinica Chimica Acta 183:243-252, 1989. |
Macarak, E.J., et al., “Production and Characterization of a Monoclonal Antibody to Human Type III Collagen,” J. Histochem. Cytochem. 34(8):1003-1011, 1986, in Chem. Abstracts 105:95762y, 1986. |
Macarak, E.J., et al., “Production and Characterization of a Monoclonal Antibody to Human Type III Collagen,” J. Histochem. and Cytochem. 34(8):1003-1011, 1986. |
Otter, A., et al., “Conformational Analysis of the Type II and III Collagen α-1 Chain N-Telopeptides by Proton-NMR Spectroscopy and Restrained Molecular Mechanics Calculations,” Biopolymers 33(9):1443-1459, 1993, in Chem. Abstracts 119:264860a, 1993. |
Gosslau, B., and H.-J. Barrach, “Enzyme-Linked Immunosorbent Microassay for Quantification of Specific Antibodies to Collagen Type I, II, and III,” J. Immunol. Meth. 29:71-77, 1979. |
Atley, L., et al., “A Selective Inhibitor of Collagenase-3 Blocks the Release of Hydroxyproline and a Metalloproteinase Specific Neopitope, Coll II CTx, From Bovine Cartilege Exposed to IL-1α,” Arth. Rheum. 40(9S):584, 1997. |
Niemelä, O., et al., “Heterogeneity of the Antigens Related to the Aminoterminal Propeptide of Type III Procollagen in Human Serum,” Clinica Chimica Acta 124:39-44, 1982. |
Atley, L.M., et al., “Matrix Metalloproteinase-Mediated Release of Immunoreactive Telopeptide From Cartilage Type II Collagen,” 44th Annual Meeting, Orthop. Res. Soc., New Orleans, Mar. 16-19, 1998. |
Moskowitz, R.W., et al., “Type II Collagen C-Telopeptide 2B4 Epitope Is a Marker for Cartilage Degradation in Familial Osteoarthritis,” Meeting of Amer. Coll. Rheum., San Diego, Nov. 8-12, 1998. |
Eyre, D.R., et al., “Biochemical Markers of Bone and Cartilage Collagen Degradation,” Combined Orthopaedic Research Societies Meeting, Vittel, France, Sep. 28-30, 1998. |
Sheridan, C., “Osteometer Targets Collagen for Osteoporosis, Arthritis Tests,” BioWorld International, Dec. 3, 1997, p. 3. |
Atley, L.M., et al., “Collagen Type II Cross-Linked Telopeptides, a Promising Marker for Cartilage Degradation in Arthritis,” Combined Orthopaedic Research Societies Meeting, Hamamatsu, Japan, 1998. |
Otter, A., et al., “Conformational Analysis of the Type II and Type III Collagen α-1 Chain N-Telopeptides by H-NMR Stpectroscopy and Restrained Molecular Mechanics Calculations,” Biopolymers 33:1443-1459, 1993. |